AMGEN REPORTS FIRST QUARTER FINANCIAL RESULTS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil gains after Trump says US will hit Iran 'very hard tonight'
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Alibaba falls on China AI capex report; Citi says selloff is premature
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Crude Inventory Fell 7.2 Million Barrels Last Week, Says EIA
- Wall Street indexes fall more than 1%, hit by tech, Iran war worries
Amgen (AMGN) falls 3% after-hours following slight Q1 revenue miss
April 27, 2023 4:12 PM EDTAmgen (NASDAQ: AMGN) falls 3% after-hours following a slight Q1 revenue miss and so-so guidance:
Amgen reported Q1 EPS of $3.98, $0.16 better than the analyst estimate of $3.82. Revenue for the quarter came in at $6.1 billion versus the consensus estimate of $6.12 billion.Amgen sees Q2... MoreAmgen (AMGN) Tops Q1 EPS by 16c
April 27, 2023 4:02 PM EDTAmgen (NASDAQ: AMGN) reported Q1 EPS of $3.98, $0.16 better than the analyst estimate of $3.82. Revenue for the quarter came in at $6.1 billion versus the consensus estimate of $6.12 billion.
GUIDANCE:
Amgen sees FY 2023 EPS of $17.60-$18.70, versus the consensus of $17.72. Amgen sees FY... More
